Slide 1: Preliminary Results for FY 2019
Preliminary Results for FY 2019 21 February 2020 RHÖN-KLINIKUM AG - Preliminary Results of 2017 - as of February 23, 2018
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any
Slide 3: Business summary of FY 2019
Business summary of FY 2019 Excessive regulatory interventions, a highly competitive landscape and the shortage of skilled workers are increasingly affecting the operating business of German hospitals with corresponding effects also for RHÖN New Campus Bad Neustadt Telemedicine via Medgate Deutschla
Slide 4: Corporate strategic direction NEW RHÖN
Corporate strategic direction Moving ahead after the transformation... Campus Concept M&A Pipeline Active role in market consolidation Unique cross-sectoral care model Campus rollout to further rural areas Acquisition of specialist healthcare providers NEW RHÖN “...Unlike its competitors, RHÖN has a
Slide 5: Preliminary results FY 2019
Preliminary results FY 2019* Volumes Revenues in million € 1,303.9 +1.2% more treated patients Total number of cases 860,528 1,232.9 +5.8% top-line Increased number of inpatient cases growth (+0.2%) and number of ambulatory treatments (+1.6%) FY 2018 FY 2019 Net Profit & Cash EBITDA in million
Slide 6: Outlook 2020
Outlook 2020 GUIDANCE Group REVENUES € 1.4bn +/- 5% 2020 Group EBITDA € 72.5m to € 82.5m Key levers and assumptions* Higher personnel costs based on wage increases and new hires Small negative double-digit € million impact on EBITDA from excessive regulations** Ramp-up effects of Medgate Deuts
Slide 7: Price regulation in 2020 at a glance
Appendix Price regulation in 2020 at a glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) DRG inflation in 2020: +3.66% L
Slide 8: Shareholder base
Appendix Shareholder base Shareholder structure as of 31 December 2019, according to the most recent notifications of voting rights at that time 25.2% 24.5%* B. Braun 24.5% Free Float 5.2% 75.5% Landeskrankenhilfe Strategic Investors 5.4% 25.1% Ingeborg Münch Asklepios 14.6% Eugen Münch/HCM SE * Sha
Slide 9: IR contact & financial calendar 2020
Appendix IR contact & financial calendar 2020 Financial calendar 2020 21 February 2020 Preliminary results for FY 2019 Conference call 24 March 2020 Publication of annual financial report 2019 IR contact Annual press conference Julian Schmitt Head of Investor Relations & Treasury 7 May 2020 Publicat